Search

Your search keyword '"Neuhausen, S.L. (Susan)"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Neuhausen, S.L. (Susan)" Remove constraint Author: "Neuhausen, S.L. (Susan)"
42 results on '"Neuhausen, S.L. (Susan)"'

Search Results

1. Erratum: Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature communications (2019) 10 1 (431))

2. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

3. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

4. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

5. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

6. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

7. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

8. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

9. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

10. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

11. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

12. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

13. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

14. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

15. Fine-mapping of the 1p11.2 breast cancer susceptibility locus

16. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

17. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

18. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

19. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1

20. Prediction of breast cancer risk based on profiling with common genetic variants

21. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

22. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression

23. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

24. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

25. Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

26. Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers

27. Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk

28. DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

29. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

30. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

31. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

32. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

33. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

34. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

35. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

36. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

37. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

38. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

39. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

40. Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (CIMBA)

41. Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

42. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

Catalog

Books, media, physical & digital resources